Initiating targeted therapy according to EULAR recommendations in patients with inflammatory joint diseases and a history of malignancy

Initiating targeted therapy according to EULAR recommendations in patients with inflammatory joint diseases and a history of malignancy

The potential link between targeted therapies and malignancies (MN) in patients with inflammatory joint diseases and a history of MNs remains a frequent concern in routine rheumatological practice.In 2024, the EULAR (European Alliance of Associations for Rheumatology) task force formulated five over...

Full description

Saved in:
Bibliographic Details
Main Authors: E. A. Trofimov, V. I. Mazurov, A. M. Lila, R. R. Samigullina, S. A. Makhortova, A. S. Trofimova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2025-06-01
Series:Современная ревматология
Subjects:
malignancy
targeted therapy
biologic therapy
immune-mediated inflammatory joint diseases
Online Access:https://mrj.ima-press.net/mrj/article/view/1772
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://mrj.ima-press.net/mrj/article/view/1772

Similar Items